Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Whole Body CD8 + T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy

Jaap A. van Doesum, Kylie Keijzer, Janneke W. de Boer, Nienke A.M. Smit, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge, Frank R. Pierik, Gerwin A. Huls, Lisanne V. van Dijk, Lydia Visser, Arjan Diepstra, Walter Noordzij, Simon P. Williams, Alexander Ungewickell, Sjoerd G. Elias, Elisabeth G.E. de Vries, Anne G.H. Niezink, Tom van Meerten

Blood (2024) 144 (Supplement 1): 1037.

https://doi.org/10.1182/blood-2024-199474

Published: 2024

Journal Articles

Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial

Paul J. Bröckelmann, Sophie Teesink, Lydia Visser, Conrad-Amadeus Voltin, Helen Kaul, Hans Schlösser, Bart-Jan Kroesen, Carsten Kobe, Peter Borchmann, Arjan Diepstra, Wouter Plattel

Blood (2024) 144 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2024-201547

Published: 2024

Journal Articles

Comparative Proteomic Profiling of Multiple Myeloma (MM) Cell Lines Identifies Mitochondrial Dysfunction As a Marker of Resistance to Proteasome Inhibitors (PIs) with Potential Therapeutic Implications for BH3-Mimetics

Tadeusz Kubicki, Kinga Bednarek, Magdalena Kostrzewska-Poczekaj, Magdalena Luczak, Lydia Visser, Monique Lodewijk, Krzysztof Żyłka, Lidia Gil, Małgorzata Jarmuż-Szymczak, Dominik Dytfeld

Blood (2024) 144 (Supplement 1): 6821.

https://doi.org/10.1182/blood-2024-203854

Published: 2024

Journal Articles

Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma

Julia Driessen, Wouter J. Plattel, Lydia Visser, Anke Van Den Berg, Josée M. Zijlstra, Sanne Tonino, Gerben JC Zwezerijnen, Ronald Boellaard, Marie José Kersten, Arjan Diepstra

Blood (2022) 140 (Supplement 1): 9213–9215.

https://doi.org/10.1182/blood-2022-166120

Published: 2022

Journal Articles

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Rebecca L. Johnston, Anja Mottok, Fong Chun Chan, Aixiang Jiang, Arjan Diepstra, Lydia Visser, Adèle Telenius, Randy D. Gascoyne, Debra L. Friedman, Cindy L. Schwartz, Kara M. Kelly, David W. Scott, Terzah M. Horton, Christian Steidl

Blood (2022) 139 (6): 889–893.

https://doi.org/10.1182/blood.2021011941

Published: 2022

Includes: Supplemental data

Journal Articles

Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58

Johanna Veldman, Lydia Visser, Magdalena Huberts-Kregel, Natasja Muller, Bouke Hepkema, Anke van den Berg, Arjan Diepstra

Blood (2020) 136 (21): 2437–2441.

https://doi.org/10.1182/blood.2020005546

Published: 2020

Includes: Supplemental data

Journal Articles

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Fazlyn Reeny Abdul Razak, Arjan Diepstra, MD PhD, Lydia Visser, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 1439.

https://doi.org/10.1182/blood.V126.23.1439.1439

Published: 2015

Journal Articles

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Joost Kluiver, PhD, Izabella Slezak-Prochazka, PhD, Melanie Winkle, Lydia Visser, PhD, Arjan Diepstra, MD PhD, Bart-Jan Kroesen, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 4820.

https://doi.org/10.1182/blood.V126.23.4820.4820

Published: 2015

Journal Articles

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

Yuxuan Liu, Anke Van Den Berg, PhD, Bea Rutgers, Rianne Veenstra, Debora de Jong, Gertrud Kortman, Gustaaf van Imhoff, Lydia Visser, Arjan Diepstra, MD PhD

Blood (2013) 122 (21): 4234.

https://doi.org/10.1182/blood.V122.21.4234.4234

Published: 2013

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

Journal Articles

Long Non-Coding RNAs Are Commonly Deregulated In Hodgkin Lymphoma

Masoumeh Tayari, Klaas Kok, Gertrud Kortman, Jantine Sietzema, Debora de Jong, Martijn Terpstra, Lydia Visser, Arjan Diepstra, MD PhD, Joost Kluiver, Anke van den Berg

Blood (2013) 122 (21): 628.

https://doi.org/10.1182/blood.V122.21.628.628

Published: 2013

Journal Articles

Strong HLA Class I Expression Is Positively Correlated with the Number of PML Nuclear Bodies and Negatively with the Percentage of SATB1 Positive HRS Cells in EBV+ Classical Hodgkin Lymphoma (cHL)

Yuxuan Liu, Lydia Visser, Rianne Veenstra, Bea Rutgers, Anke Van Den Berg, PhD, Arjan Diepstra, MD PhD

Blood (2012) 120 (21): 3633.

https://doi.org/10.1182/blood.V120.21.3633.3633

Published: 2012

Journal Articles

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

Zheng Liang, MD, Arjan Diepstra, MD PhD, Chuanhui Xu, MD PhD, Gustaaf W van Imhoff, MD, PhD, Wouter J Plattel, MD, Anke Van Den Berg, PhD, Lydia Visser, PhD

Blood (2012) 120 (21): 2640.

https://doi.org/10.1182/blood.V120.21.2640.2640

Published: 2012

Journal Articles

CCR4 Expression in Hodgkin Lymphoma

Lydia Visser, Myrna van West, Bea Rutgers, Sibrand Poppema, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 2626.

https://doi.org/10.1182/blood.V118.21.2626.2626

Published: 2011

Journal Articles

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

Kushi Kushekhar, Rianne Veenstra, Gabriela Gualco, Pollyanna Domeney, MD, Bouke Hepkema, PhD, Lydia Visser, PhD, Carlos E Bacchi, MD, Arjan Diepstra, MD, PhD, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 4858.

https://doi.org/10.1182/blood.V118.21.4858.4858

Published: 2011

Journal Articles

Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups

Xin Huang, Kushi Kushekhar, Ilja Nolte, Wierd Kooistra, Lydia Visser, Ilby Bouwman, Niels Kouprie, Rianne Veenstra, Gustaaf van Imhoff, Bianca Olver, Richard S. Houlston, Sibrand Poppema, Arjan Diepstra, Bouke Hepkema, Anke van den Berg

Blood (2011) 118 (19): 5211–5217.

https://doi.org/10.1182/blood-2011-04-342998

Published: 2011

Includes: Supplemental data

Journal Articles

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Wouter Plattel, MD, Anke Van Den Berg, PhD, Anne Marijn Van der Graaf, Hans Vos, Lydia Visser, PhD, Arjan Diepstra, MD, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2010) 116 (21): 748.

https://doi.org/10.1182/blood.V116.21.748.748

Published: 2010

Journal Articles

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Arjan Diepstra, MD, PhD, Xin Huang, Ilja Nolte, PhD, Bouke Hepkema, PhD, Wierd Kooistra, Lydia Visser, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 749.

https://doi.org/10.1182/blood.V116.21.749.749

Published: 2010

Journal Articles

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Chuanhui Xu, Anke Van Den Berg, PhD, Wouter Plattel, drs., Nele Ruther, Huang Xin, Sr, Miao Wang, Gustaaf Van Imhoff, MD, PhD, Andreas Viardot, Peter Möller, Sibrand Poppema, MD, PhD, Lydia Visser, PhD

Blood (2010) 116 (21): 3880.

https://doi.org/10.1182/blood.V116.21.3880.3880

Published: 2010

Journal Articles

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Huang Xin, MD, Arjan Diepstra, MD, PhD, Zifen Gao, MD, PhD, Lydia Visser, PhD, Hans Vos, Wierd Kooistra, Sibrand Poppema, MD, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 2688.

https://doi.org/10.1182/blood.V116.21.2688.2688

Published: 2010

NARROW

Whole Body CD8 + T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy

Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial

Comparative Proteomic Profiling of Multiple Myeloma (MM) Cell Lines Identifies Mitochondrial Dysfunction As a Marker of Resistance to Proteasome Inhibitors (PIs) with Potential Therapeutic Implications for BH3-Mimetics

Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma

A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma

Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Long Non-Coding RNAs Are Commonly Deregulated In Hodgkin Lymphoma

Strong HLA Class I Expression Is Positively Correlated with the Number of PML Nuclear Bodies and Negatively with the Percentage of SATB1 Positive HRS Cells in EBV+ Classical Hodgkin Lymphoma (cHL)

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

CCR4 Expression in Hodgkin Lymphoma

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only